We are live on
!
Find out more
Jim Simons Renaissance Technologies
AUM
$63.9B
1-Year Est. Return
45.56%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
1 Year Est. Return
+45.56%
AUM
$63.9B
AUM Growth
-$531M
(-0.82%)
Holding
3,809
Top Buys
| 1 | +$800M | |
| 2 | +$304M | |
| 3 | +$261M | |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| 1 | +$656M | |
| 2 | +$632M | |
| 3 | +$474M | |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.12% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vodafone
VOD
$35.8B
| $58.7M | 0.09% |
3,906,751
-841,056
|
|
||
277
Travere Therapeutics
TVTX
$4.84B
| $58.4M | 0.09% |
1,966,779
-280,000
|
|
||
278
Cigna
CI
$78.8B
| $58.4M | 0.09% |
218,939
+172,219
|
|
||
279
Catalyst Pharmaceutical
CPRX
$3.84B
| $58.1M | 0.09% |
2,347,477
-302,600
|
|
||
280
Pinnacle West Capital
PNW
$12.5B
| $58M | 0.09% |
576,100
+162,700
|
|
||
281
BioMarin Pharmaceuticals
BMRN
$10.8B
| $57.9M | 0.09% |
1,024,871
-300,100
|
|
||
282
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.6B
| $57.8M | 0.09% |
530,436
+515,600
|
|
||
283
Alphabet (Google) Class C
GOOG
$4.37T
| $57.7M | 0.09% |
201,002
+98,921
|
|
||
284
Descartes Systems
DSGX
$6.25B
| $57.2M | 0.09% |
798,844
+125,900
|
|
||
285
AB InBev
BUD
$160B
| $56.3M | 0.09% |
810,874
+318,600
|
|
||
286
Aecom
ACM
$9.01B
| $56.2M | 0.09% |
662,277
+24,700
|
|
||
287
Regions Financial
RF
$25B
| $56M | 0.09% |
2,144,021
+597,600
|
|
||
288
Viking Holdings
VIK
$41.2B
| $55.8M | 0.09% |
759,204
-13,400
|
|
||
289
PTC
PTC
$13.1B
| $55.4M | 0.09% |
389,100
+183,600
|
|
||
290
Blue Owl Capital
OWL
$6.54B
| $55.4M | 0.09% |
6,065,200
+5,790,400
|
|
||
291
Takeda Pharmaceutical
TAK
$50.3B
| $55.4M | 0.09% |
2,989,100
+370,800
|
|
||
292
Madison Square Garden
MSGS
$9.26B
| $55.3M | 0.09% |
172,000
+54,100
|
|
||
293
Opendoor
OPEN
$4.28B
| $55.3M | 0.09% |
11,810,938
-27,519,500
|
|
||
294
Centene
CNC
$32.2B
| $55.2M | 0.09% |
1,684,669
+632,557
|
|
||
295
Crown Holdings
CCK
$11.1B
| $54.9M | 0.09% |
548,000
+70,300
|
|
||
296
Ezcorp Inc
EZPW
$1.92B
| $54.8M | 0.09% |
2,157,366
-196,862
|
|
||
297
Unity
U
$11.9B
| $54.5M | 0.09% |
+2,485,597
|
|
||
298
Gaming and Leisure Properties
GLPI
$13.4B
| $54.2M | 0.08% |
1,221,330
+575,000
|
|
||
299
AngloGold Ashanti
AU
$43.6B
| $54.2M | 0.08% |
+556,200
|
|
||
300
Carlisle Companies
CSL
$13.9B
| $53.9M | 0.08% |
161,460
+51,440
|
|